Biosimilar drugs, Egualia “The challenge is to preserve the Italian model”
ROMA (ITALPRESS) – Ten years ago Law 232/2016 introduced a model that over time has established itself as a reference at European level, helping to combine access to biosimilar drugs, prescribed freedom of the doctor and sustainability of the National […]
Biosimilar drugs, Egualia “The challenge is to preserve the Italian model” Read More »










